FibroBiologics (FBLG) Revenue & Revenue Breakdown
FibroBiologics Revenue Highlights
00
FibroBiologics Revenue by Period
FibroBiologics Revenue by Year
| Date | Revenue | Change |
|---|---|---|
| 2024-12-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2021-12-31 | - | 100.00% |
| 2020-12-31 | - | - |
FibroBiologics generated - in revenue during NA 2024, up 100.00% compared to the previous quarter, and up 0.00% compared to the same period a year ago.
FibroBiologics Revenue by Quarter
| Date | Revenue | Change |
|---|---|---|
| 2025-09-30 | - | 100.00% |
| 2025-06-30 | - | 100.00% |
| 2025-03-31 | - | -100.00% |
| 2024-12-31 | $554.00K | 100.00% |
| 2024-09-30 | - | 100.00% |
| 2024-06-30 | - | 100.00% |
| 2024-03-31 | - | 100.00% |
| 2023-12-31 | - | 100.00% |
| 2023-09-30 | - | 100.00% |
| 2023-06-30 | - | 100.00% |
| 2023-03-31 | - | 100.00% |
| 2022-12-31 | - | 100.00% |
| 2022-09-30 | - | 100.00% |
| 2022-06-30 | - | 100.00% |
| 2022-03-31 | - | - |
FibroBiologics generated - in revenue during Q3 2025, up 100.00% compared to the previous quarter, and up NaN% compared to the same period a year ago.
FibroBiologics Peer Comparison by Revenue
| Ticker | Company | Last Year Revenue | Last Quarter Revenue |
|---|---|---|---|
| ADTX | Aditxt | $133.99M | $748.00 |
| DARE | Daré Bioscience | $9.78M | $-21.17K |
| ICU | SeaStar Medical | $135.00K | $338.00K |
| APLM | Apollomics | - | - |
| CTXR | Citius Pharmaceuticals | - | - |
| AIMD | Ainos | - | $4.66K |
| MBRX | Moleculin Biotech | - | - |
| LPTX | Leap Therapeutics | - | - |
| ATHA | Athira Pharma | - | - |
| HOTH | Hoth Therapeutics | - | - |
| FBLG | FibroBiologics | - | - |